- Home
- RNAZ vs MARPS Comparison
RNAZ vs MARPS Comparison
Compare RNAZ & MARPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- MARPS
- Stock Information
- Founded
- RNAZ 2016
- MARPS 1956
- Country
- RNAZ United States
- MARPS United States
- Employees
- RNAZ N/A
- MARPS N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- MARPS Oil & Gas Production
- Sector
- RNAZ Health Care
- MARPS Energy
- Exchange
- RNAZ Nasdaq
- MARPS Nasdaq
- Market Cap
- RNAZ 7.2M
- MARPS 7.8M
- IPO Year
- RNAZ 2021
- MARPS N/A
- Fundamental
- Price
- RNAZ $0.53
- MARPS $3.92
- Analyst Decision
- RNAZ Strong Buy
- MARPS
- Analyst Count
- RNAZ 1
- MARPS 0
- Target Price
- RNAZ $20.00
- MARPS N/A
- AVG Volume (30 Days)
- RNAZ 16.6M
- MARPS 2.6K
- Earning Date
- RNAZ 05-14-2025
- MARPS 01-01-0001
- Dividend Yield
- RNAZ N/A
- MARPS 8.44%
- EPS Growth
- RNAZ N/A
- MARPS N/A
- EPS
- RNAZ N/A
- MARPS 0.30
- Revenue
- RNAZ N/A
- MARPS $945,496.00
- Revenue This Year
- RNAZ $180.81
- MARPS N/A
- Revenue Next Year
- RNAZ N/A
- MARPS N/A
- P/E Ratio
- RNAZ N/A
- MARPS $13.05
- Revenue Growth
- RNAZ N/A
- MARPS N/A
- 52 Week Low
- RNAZ $0.43
- MARPS $3.76
- 52 Week High
- RNAZ $66.33
- MARPS $6.50
- Technical
- Relative Strength Index (RSI)
- RNAZ 28.52
- MARPS 51.16
- Support Level
- RNAZ $0.43
- MARPS $3.85
- Resistance Level
- RNAZ $0.61
- MARPS $3.95
- Average True Range (ATR)
- RNAZ 0.17
- MARPS 0.03
- MACD
- RNAZ 0.21
- MARPS 0.01
- Stochastic Oscillator
- RNAZ 8.24
- MARPS 52.94
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.
About MARPS Marine Petroleum Trust Units of Beneficial Interest
Marine Petroleum Trust is a U.S based royalty trust. It provides administration and liquidation of rights to payments from oil and natural gas leases in the Gulf of Mexico. The Trust's subsidiary holds title to interests in properties which are situated offshore of Louisiana. The revenues of the trust are derived from the oil and natural gas production activities of third parties.